Mr. Jonathan H. Chou is a seasoned finance and operations executive with leadership experience with Fortune 500 and Asia headquartered U.S. listed companies. Mr. Chou is currently CFO of UTAC group responsible for finance, corporate HR and IT. Prior to UTAC, he was CFO of Kulicke & Soffa (Nasdaq: KLIC), a $2B market capitalization semiconductor packaging and electronic assembly solutions provider, from 2010 to 2018. Before Kulicke and Soffa, he was the CFO for Feihe International, a Sequoia Capital portfolio company. His efforts led to a successful listing on the Main Board of the New York Stock Exchange in 2009. Earlier on in his ascending career, he held the Asia Pacific CFO and senior finance positions with various Fortune 500 companies, including Honeywell, Tyco ADT, Lucent Technologies (Bell Labs), and Public Service Enterprise Group (PSEG).
He currently serves on two board of directors roles i.e. MicroPort Scientific since its 2010 IPO and more recently invited to join Microport CardioFlow MedTech period to its IPO in February 2021. Mr. Chou also volunteers his time and serves as a Director of Emerging Markets Investors Alliance, a 501(c)(3) not-for-profit organization that enables institutional investors to support good governance, promote sustainable development and improve performance in the governments and companies they invest in.
Mr. Chou holds a B.A. in Economics from the University at Buffalo and an MBA from Duke University's Fuqua School of Business. He is a recipient of CFO World Magazine's "China's Top 10 CFO's" award for 2008 related to navigating through the Global Financial Crisis. Mr. Chou and his wife Doreen recently spent three enjoyable years in the US and returned to Asia in February of 2021.